Prior Auth Required

0026U - probability of malignancy" or "Negative, low probability of malignancy")

This procedure appears on the selected insurer prior authorization source.

Check another codeExplore policy data
Prior authorizationPrior Auth Required
Procedure / Serviceprobability of malignancy" or "Negative, low probability of malignancy")
Procedure / Service Description

Targeted genomic sequence analysis panel, non-small cell lung neoplasia, DNA and RNA - Oncology (thyroid), DNA and mRNA of 112 genes, next-generation sequencing, fine needle aspirate of thyroid nodule, algorithmic analysis reported as a categorical result ("Positive, high 0026U probability of malignancy" or "Negative, low probability of malignancy") JAK2 (Janus kinase 2) (eg, myeloproliferative disorder) gene analysis, targeted sequence 0027U analysis exons 12-15

Likely documents
  • Confirm benefit details
  • Submit clinical notes if requested by the plan
Next actions
  • Confirm the current plan policy before submission.
  • Use the insurer authorization workflow for this listed code.